Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$100.93
$101.02
50-Day Range
$96.91
$101.01
52-Week Range
$92.44
$101.02
Volume
1.06 million shs
Average Volume
509,062 shs
Market Capitalization
$3.32 billion
P/E Ratio
39.30
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AMED Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys, Inc. (NASDAQ:AMED) issued its quarterly earnings results on Tuesday, July, 29th. The health services provider reported $1.54 EPS for the quarter, topping the consensus estimate of $1.39 by $0.15. The company's revenue for the quarter was up 5.2% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
7/29/2025
Today
5/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:AMED
CIK
896262
Employees
20,000
Year Founded
1982

Profitability

EPS (Trailing Twelve Months)
$2.57
Trailing P/E Ratio
39.30
Forward P/E Ratio
22.96
P/E Growth
1.34
Net Income
$43.23 million
Net Margins
3.56%
Pretax Margin
6.21%
Return on Equity
12.91%
Return on Assets
7.29%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
1.36
Quick Ratio
1.36

Sales & Book Value

Annual Sales
$2.40 billion
Price / Sales
1.38
Cash Flow
$6.24 per share
Price / Cash Flow
16.20
Book Value
$38.77 per share
Price / Book
2.61

Miscellaneous

Outstanding Shares
32,887,000
Free Float
32,196,000
Market Cap
$3.32 billion
Optionable
Optionable
Beta
0.89

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners